ATXN3 and Cataplexy: These findings were confirmed in a separate group of orexin/ataxin-3 mice with video recording used to confirm immobility during cataplexy-like episodes, in addition to locomotor activity recording, with danavorexton 1 mg/kg (P ≤ 0.01; SI Appendix, Fig. S1G).